# Genecast Biotechnology

Source: https://onco.cc/companies/genecast/  
OnCo record `genecast` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A Wuxi genomics company that co-developed TOTEM, a methylation blood test for seven cancers.

## Summary

Genecast Biotechnology Co., Ltd., of Wuxi, Jiangsu, according to its authors' affiliations, co-developed TOTEM, a cell-free DNA methylation test for seven cancers with a predicted origin (BMC Cancer 2024).

## Fields

- Kind: Company
- Last checked: 2026-11-03
- Also known as: Genecast
- HQ: Wuxi
- Type: diagnostics

## Sources

- TOTEM, BMC Cancer 2024: https://doi.org/10.1186/s12885-024-12626-7

## Connected records

- fronts: [Diagnostics & Biomarkers](https://onco.cc/fronts/diagnostics/), [Early Detection & Screening](https://onco.cc/fronts/early-detection/)
- technologies: [Cell-free DNA methylation tests](https://onco.cc/technologies/cfdna-methylation-testing/), [Liquid biopsy (ctDNA)](https://onco.cc/technologies/liquid-biopsy/), [Multi-cancer early detection (MCED)](https://onco.cc/technologies/mced/)
- drugs: [TOTEM (Genecast)](https://onco.cc/drugs/totem-genecast/)
- key papers: [TOTEM: a multi-cancer detection and localization approach using circulating tumor DNA methylation markers](https://onco.cc/key-papers/paper-totem-genecast-bmc-cancer-2024/)

---
JSON: https://onco.cc/api/v1/entities/genecast.json